---
layout: default
title: Curriculum Vitae
description: 
---

## Education

|:---------------------------------------------|:-----------------------------------------------------------------------------|
| Doctor of Philosophy (Ph.D.), Pharmacology   | Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON. |
| Master of Science (M.Sc.), Neuroscience      | Centre for Neuroscience Studies, Queen’s University, Kingston, ON.           |
| Bachelor of Science (Honours) (H.B.Sc.) Neuroscience and Biochemistry majors, Psychology minor | University of Toronto - St. George Campus, Toronto, ON


## Publications

**Islam, F.**, Marshe, V.S., Magarbeh, L., Frey, B.N., Milev, R.V., Soares, C., Parikh, S., Placenza, F., Strother, S.C., Hassel, S., Taylor, V.H., Leri, F., Blier, P., Uher, R., Farzan, F., Lam, R.W., Turecki, G., Foster, J.A., Rotzinger, S., Kennedy, S.H., Müller, D.J. (2022) [Effects of CYP2C19 and CYP2D6 Gene Variants on Escitalopram and Aripiprazole Treatment Outcome and Serum Levels: Results from the CAN-BIND 1 Study](https://www.nature.com/articles/s41398-022-02124-4). Translational Psychiatry. 12, 366.

**Islam, F.**, Hain, D., Lewis, D., Law, R., Brown, L., Tanner, J-A., & Müller, D.J. (2022) [Pharmacogenetics of Clozapine-induced Agranulocytosis: A Systematic Review and Meta-Analysis](https://www.nature.com/articles/s41397-022-00281-9). The Pharmacogenomics Journal. DOI: 10.1038/s41397-022-00281-9

**Islam, F.**, Men, X., Yoshida, K., Zai, C.C., & Müller, D.J. (2021) [Pharmacogenetics-guided advances in antipsychotic treatment](https://pubmed.ncbi.nlm.nih.gov/34129738/). Clinical Pharmacology and Therapeutics. 110(3), 582-588.

**Islam, F.**, Gorbovskaya, I., & Müller, D.J. (2021) [Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression. In: Kim YK. (eds) Major Depressive Disorder](https://pubmed.ncbi.nlm.nih.gov/33834403/). Advances in Experimental Medicine and Biology, vol 1305. Springer, Singapore. 

**Islam, F.**, Maciukiewicz, M., Freeman, N., Eric, H., Tiwari, A., Mulsant, B.H., Pollock, B.G., Remington, G., Kennedy, J.L, Müller, D.J., & Rajji, TK. (2021) [Contributions of Cholinergic Receptor Muscarinic 1 (CHRM1) and CYP1A2 Gene Variants on the Effects of Plasma Ratio of Clozapine/N-Desmethylclozapine on Working Memory in Schizophrenia](https://pubmed.ncbi.nlm.nih.gov/33143542/). Journal of Psychopharmacology. 35(1), 31-39.

Marshe, V.S., Maciukiewicz, M., Hauschild, A-C., **Islam, F.**, Qin, L., Tiwari, A.K., Sibille, E., Blumberger, D.M., Karp, J.F., Flint, A.J., Kennedy, S.H., Lam, R.W., Frey, B., CAN-BIND Investigator Team, Kennedy, J.L., Mulsant, B.H., Reynolds III, C.F., Lenze, E.J., & Müller, D.J. (2021) [Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response](https://www.nature.com/articles/s41398-021-01248-3). Translational Psychiatry. 11(1), 1-12. 

Marshe, V.S., **Islam, F.**, Maciukiewicz, M., Fiori, L.M., Yerko, V., Yang, J., Turecki, G., Foster, J.A., Kennedy, S.H., Blumberger, D.M., Karp, J.F., Kennedy, J.L., Muslant, B.H., Reynolds, C.F. 3rd, Lenze, E.J., & Müller, D.J. (2020) [Validation study of microRNAs previously associated with antidepressant response in older adults treated for late-life depression with venlafaxine](https://pubmed.ncbi.nlm.nih.gov/31954757/). Progress in Neuro-Psychopharmacology & Biological Psychiatry. 100, 109867.

Marshe, V.S., **Islam, F.**, Maciukiewicz, M., Bousman, C., Eyre, H.A., Lavretsky, H., Muslant, B.H., Reynolds, C.F. 3rd, Lenze, E.J., & Müller, D.J. (2020) [Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions](https://pubmed.ncbi.nlm.nih.gov/32122803/). American Journal of Geriatric Psychiatry. 28(6), 609.

**Islam, F.**, Voineskos, A., Mulsant, B.H., & Rajji, TK. [Expression of brain derived neurotrophic factor in individuals with schizophrenia and healthy aging: testing the accelerated aging hypothesis in schizophrenia](https://pubmed.ncbi.nlm.nih.gov/28534294/). (2017) Current Psychiatry Reports. 19 (7), 36.

**Islam, F.**, Xu, K., & Beninger, R.J. [Inhibition of Wnt signalling dose-dependently impairs the acquisition and expression of amphetamine-induced conditioned place preference](https://pubmed.ncbi.nlm.nih.gov/28284949/). (2017) Behavioural Brain Research. 326, 217-225.


[back](./)
